Moleculin Biotech (MBRX) Tops Q1 EPS by 209c
Moleculin Biotech (NASDAQ: MBRX) reported Q1 EPS of ($0.69), $2.09 better than the analyst estimate of ($2.78).
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.
Moleculin Biotech (NASDAQ: MBRX) reported Q1 EPS of ($0.69), $2.09 better than the analyst estimate of ($2.78).
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.